🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03211Q200 (prev. 01438T106 )
- Market Cap
- Small Cap
- IPO
- 5/1/2014 · $8.00/share
- Previous Name
- Aldexa Therapeutics, Inc.
Business: Aldeyra Therapeutics, Inc. is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra's lead investigational drug product candidates are first-in-class potential treatments in development for dry eye disease, allergic conjunctivitis, proliferative vitreoretinopathy, and Sjögren-Larsson Syndrome. The company is also developing other product candidates for retinal and systemic inflammatory diseases.
Company Contact
- CEO
- Todd C. Brady
- CFO
- Bruce Greenberg
- Headquarters
- 131 Hartwell Avenue, Suite 320, Lexington, MA 02421
- Phone
- 781-761-4904
- Investor Relations
- Chris Brinzey, Westwicke · 339-970-2843 · Chris.brinzey@westwicke.com